Provided by Tiger Fintech (Singapore) Pte. Ltd.

LUCID DIAGNOSTICS INC.

1.39
+0.11008.59%
Post-market: 1.420.0287+2.06%19:59 EDT
Volume:1.22M
Turnover:1.70M
Market Cap:101.86M
PE:-1.24
High:1.46
Open:1.31
Low:1.29
Close:1.28
Loading ...

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025

PR Newswire
·
10 Mar

BRIEF-Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering

Reuters
·
06 Mar

Lucid Diagnostics Raises $15.3 Million in Stock Offering

TIPRANKS
·
06 Mar

Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering

THOMSON REUTERS
·
06 Mar

Lucid Diagnostics Prices $15.3 Million Direct Offering

MT Newswires Live
·
04 Mar

Lucid Diagnostics to sell 13.94M shares at $1.10 in registered direct offering

TIPRANKS
·
04 Mar

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering

PR Newswire
·
04 Mar

Lucid Diagnostics Inc: Announces $15.3 Million Registered Direct Offering

THOMSON REUTERS
·
04 Mar

Lucid Diagnostics Inc - Terminates Atm Prospectus Supplement Dated Dec 6, 2022

THOMSON REUTERS
·
04 Mar

Renowned Investigators Awarded $8 Million Nih Grant to Study Lucid Diagnostics' Esoguard® in at-Risk Patients Without Symptomatic Gerd

THOMSON REUTERS
·
27 Feb

Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERD

PR Newswire
·
27 Feb

Lucid Diagnostics Regains Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS
·
25 Feb

Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement

PR Newswire
·
25 Feb

Lucid Diagnostics Inc - Regains Compliance With Nasdaq $1 Minimum Bid Price on Feb 24

THOMSON REUTERS
·
25 Feb

BRIEF-PAVmed Regains Compliance With Nasdaq Stockholders' Equity Requirement

Reuters
·
18 Feb

PAVmed Regains Compliance With Nasdaq Stockholders' Equity Requirement

THOMSON REUTERS
·
18 Feb